- Home
- FIVN vs PRCT Comparison
FIVN vs PRCT Comparison
Compare FIVN & PRCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FIVN
- PRCT
- Stock Information
- Founded
- FIVN 2001
- PRCT 2009
- Country
- FIVN United States
- PRCT United States
- Employees
- FIVN N/A
- PRCT N/A
- Industry
- FIVN EDP Services
- PRCT Medical Specialities
- Sector
- FIVN Technology
- PRCT Health Care
- Exchange
- FIVN Nasdaq
- PRCT Nasdaq
- Market Cap
- FIVN 2.0B
- PRCT 2.2B
- IPO Year
- FIVN 2014
- PRCT 2021
- Fundamental
- Price
- FIVN $27.57
- PRCT $41.23
- Analyst Decision
- FIVN Buy
- PRCT Buy
- Analyst Count
- FIVN 19
- PRCT 8
- Target Price
- FIVN $39.16
- PRCT $75.57
- AVG Volume (30 Days)
- FIVN 2.5M
- PRCT 1.4M
- Earning Date
- FIVN 07-31-2025
- PRCT 08-06-2025
- Dividend Yield
- FIVN N/A
- PRCT N/A
- EPS Growth
- FIVN N/A
- PRCT N/A
- EPS
- FIVN 0.11
- PRCT N/A
- Revenue
- FIVN $1,105,816,000.00
- PRCT $274,950,000.00
- Revenue This Year
- FIVN $12.39
- PRCT $47.51
- Revenue Next Year
- FIVN $9.39
- PRCT $31.69
- P/E Ratio
- FIVN $253.57
- PRCT N/A
- Revenue Growth
- FIVN 14.21
- PRCT 55.71
- 52 Week Low
- FIVN $21.04
- PRCT $37.12
- 52 Week High
- FIVN $49.90
- PRCT $103.81
- Technical
- Relative Strength Index (RSI)
- FIVN 56.76
- PRCT 35.88
- Support Level
- FIVN $24.93
- PRCT $38.67
- Resistance Level
- FIVN $27.07
- PRCT $42.71
- Average True Range (ATR)
- FIVN 1.22
- PRCT 2.18
- MACD
- FIVN 0.20
- PRCT 0.19
- Stochastic Oscillator
- FIVN 95.58
- PRCT 32.17
About FIVN Five9 Inc.
Five9 offers cloud-native contact center software enabling digital customer service, sales, and marketing engagement. The company's Virtual Contact Center platform combines core telephony functionality, omnichannel engagement, and various modules into a unified cloud contact-center-as-a-service, or CCaaS, platform. Five9's modules include digital self-service, agent assist technology, workflow automation, as well as workforce optimization solutions that optimize call center efficiency, and manage interaction quality and agent performance.
About PRCT PROCEPT BioRobotics Corporation
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, which are image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.